sybd management





		SYBD’s management team represents decades of experience and expertise in biomedical product R&D, regulatory and clinical affairs, GMP compliant manufacturing, international business, and global marketing. Robert Nicora President & CEO Mr. Nicora has more than 30 years of domestic and international experience in various laboratory, management and regulatory positions with major pharmaceutical and medical device companies. David Johnson Chief Financial Officer Mr. Johnson has more than 25 years of experience in financial and administrative management positions in various industries, including 18 years as a partner in a major public accounting firm. Richard Kiral, PhD Vice President, Product Development Dr. Kiral, an expert in analytical chemistry, has held senior product development, laboratory management, and R&D positions at leading pharmaceutical and medical device companies for more than 20 years. Douglas Kornbrust, PhD Consultant, Preclinical Toxicology and Pharmacology Dr. Kornbrust has more than 20 years of experience in research and technical management in developing and implementing preclinical toxicology and pharmacology programs for numerous biomedical products, including perfluorocarbon liquid ventilation and blood substitute products. Anthony Fox, MD, PhD Consulting Clinical Pharmacologist Dr. Fox currently is President of the consulting firm, EBD Group. Previous senior positions were with Cypros Pharmaceuticals, Glaxo Inc., and Procter and Gamble Pharmaceuticals.